Foundation Medicine, Inc., a genomic company committed to transforming cancer care, today announced that the company and its collaborators will present more than 15 abstracts demonstrating the value ...
The MarketWatch News Department was not involved in the creation of this content. --Discovery of a Novel Covalent FGFR3 Inhibitor with Potent Anti-Cancer Activity --Discovery of a First-in-Class ...
RICHMOND, Calif.--(BUSINESS WIRE)--Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted nine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback